Biofrontera Ag Financial Statements
71 Followers
Biofrontera Ag Financial Overview
Biofrontera Ag's market cap is currently ―. The company's EPS TTM is $0.613; its P/E ratio is 4.01; Biofrontera Ag is scheduled to report earnings on August 18, 2022, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 20 | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 30.35M | € 31.27M | € 21.11M | € 12.03M | € 6.13M |
| Gross Profit | € 26.81M | € 26.39M | € 16.66M | € 10.31M | € 4.48M |
| EBIT | € -9.62M | € -2.07M | € -17.48M | € -14.97M | € -9.37M |
| EBITDA | € -4.28M | € 1.09M | € -16.73M | € -14.09M | € -8.54M |
| Net Income Common Stockholders | € -13.02M | € -7.36M | € -8.88M | € -15.25M | € -10.58M |
| Balance Sheet | |||||
| Cash, Cash Equivalents and Short-Term Investments | € 11.65M | € 12.20M | € 15.80M | € 17.08M | € 20.25M |
| Total Assets | € 56.39M | € 58.36M | € 39.13M | € 19.85M | € 23.88M |
| Total Debt | € 3.76M | € 12.53M | € 13.74M | € 23.25M | € 23.95M |
| Net Debt | € -7.89M | € 330.00K | € -2.06M | € 6.17M | € 3.70M |
| Total Liabilities | € 49.02M | € 48.41M | € 22.78M | € 16.47M | € 8.04M |
| Stockholders Equity | € 3.38M | € 7.38M | € 9.95M | € 15.84M | € 16.36M |
| Cash Flow | |||||
| Free Cash Flow | € -3.62M | € -34.75M | € -13.95M | € -13.52M | € -10.74M |
| Operating Cash Flow | € -2.85M | € -32.89M | € -13.43M | € -13.12M | € -10.26M |
| Investing Cash Flow | € 2.87M | € 21.05M | € -511.00K | € -375.00K | € -455.00K |
| Financing Cash Flow | € 5.95M | € 3.46M | € 22.27M | € 9.45M | € 21.88M |
Biofrontera Ag Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.